Shanghai Pharmaceuticals Holding Stock Current Asset
S1R Stock | EUR 1.58 0.01 0.63% |
Shanghai Pharmaceuticals Holding fundamentals help investors to digest information that contributes to Shanghai Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Shanghai Stock. The fundamental analysis module provides a way to measure Shanghai Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Pharmaceuticals stock.
Shanghai |
Shanghai Pharmaceuticals Holding Company Current Asset Analysis
Shanghai Pharmaceuticals' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
In accordance with the recently published financial statements, Shanghai Pharmaceuticals Holding has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Distribution industry. The current asset for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Shanghai Fundamentals
Return On Equity | 0.1 | |||
Return On Asset | 0.0281 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.04 % | |||
Current Valuation | 8.94 B | |||
Shares Outstanding | 919.07 M | |||
Shares Owned By Insiders | 22.00 % | |||
Shares Owned By Institutions | 32.12 % | |||
Price To Earning | 6.59 X | |||
Price To Book | 0.67 X | |||
Price To Sales | 0.04 X | |||
Revenue | 215.82 B | |||
Gross Profit | 28.41 B | |||
EBITDA | 10.73 B | |||
Net Income | 5.09 B | |||
Cash And Equivalents | 23.68 B | |||
Cash Per Share | 8.33 X | |||
Total Debt | 7.16 B | |||
Debt To Equity | 0.67 % | |||
Current Ratio | 1.23 X | |||
Book Value Per Share | 17.90 X | |||
Cash Flow From Operations | 5.06 B | |||
Earnings Per Share | 0.23 X | |||
Price To Earnings To Growth | 2.42 X | |||
Number Of Employees | 47.06 K | |||
Beta | 0.33 | |||
Market Capitalization | 9.17 B | |||
Total Asset | 163.44 B | |||
Z Score | 1.6 | |||
Annual Yield | 0.04 % | |||
Five Year Return | 2.74 % | |||
Net Asset | 163.44 B | |||
Last Dividend Paid | 0.42 |
About Shanghai Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Pharmaceuticals Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Pharmaceuticals Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.